.Merck defeats revenues requirements, raises purchases outlook on solid need for top medicines like Keytruda CNBCMerck & Co. (MRK United States) Defeats Profit Estimates as Keytruda Sales Growth BloombergMerck Sell: Pharma Giant Posts Solid Outcomes, Yet Overview Falls Short Financier's Organization DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck trumps income and also sales assumptions amid Keytruda strong point, but offers combined full-year expectation MarketWatch.